TIL - Instil Bio Inc.

Momentum: Bearish

Recent News

Instil Bio ( NASDAQ:TIL ) , a clinical-stage biotechnology company focused on developing immunotherapies for cancer, released its second quarter 2025 earnings on August 13, 2025. The report highlighted ongoing pipeline investment but underscored a widening loss and higher research costs.

Bullish

Instil Bio, Inc. ( TIL ) Is Up 4.07% in One Week: What You Should Know

Zacks Commentary • 2 months, 3 weeks ago • score: 0.41

Does Instil Bio, Inc. (TIL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Bullish

Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. ( TIL ) is a Great Choice

Zacks Commentary • 3 months, 1 week ago • score: 0.41

Does Instil Bio, Inc. (TIL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas.

52W High

$92.00

52W Low

$10.80

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

2.18

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.62

EV/Revenue (<3 favorable)

43213.95

P/S (TTM) (<3 favorable)

55329.79

P/B (<3 favorable)

1.62

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

6.32%

Institutions (25–75% balanced)

69.62%

Shares Outstanding

6,750,700

Float

3,308,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

138,000

EPS (TTM)

-12.91

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.52%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.7854

-0.5869

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025